Lifeloc Technologies GAAP EPS of -$0.03, revenue of $2.52M

Lifeloc Technologies reported Q3 GAAP EPS of -$0.03 and revenue of $2.52M, up 12.0% year-over-year, according to the company's press release.

Original reporting
Published Nov 16, 2026, 7:14 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 16, 2026, 7:22 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$LCTC
Bearish
medium confidence
Mentioned
$LCTC
Relevance
8/10
AlphAI data visualization · based on seekingalpha.com
Decision brief

The 30-second read

$LCTCBearishMed
01

Why it matters

Traders can update near-term expectations for profitability trajectory based on the reported loss and revenue growth, but the lack of guidance limits forward positioning.

02

Market read

A fresh quarterly earnings datapoint for LCTC, highlighting continued GAAP losses despite year-over-year revenue growth.

03

What to watch

No guidance, cash flow, backlog, gross margin, or expense trend is provided, which are often the key drivers of post-earnings repricing.

Relevance 8/10Novelty 8/10Timing: reported Q3 results (Nov 16, 2026, 2:14 PM ET)

Background

The piece summarizes Lifeloc Technologies’ Q3 earnings release with GAAP EPS and revenue figures.

Company-level read

Ticker impact

$LCTCBearishMedium confidence
Context

Article reports Lifeloc Technologies Q3 GAAP EPS of -$0.03 and revenue of $2.52M, a direct earnings datapoint for the stock.

Expected impact

Likely downside or volatility as traders weigh continued losses against the reported revenue growth.

Evidence & confidence

The only disclosed figures are GAAP EPS and revenue; without guidance or segment detail, the market reaction typically hinges on whether losses are narrowing, which is not provided here.

Market effects

Limited read-through because the article provides no peer or sector context beyond a single small-cap healthcare/medical device earnings print.

None indicated.

None indicated.

Counterpoint

Revenue growth (+12% Y/Y) could be viewed as early traction, and the GAAP loss may reflect non-cash charges or investment spending not captured by operating cash flow.

Key entities

  • Lifeloc Technologies, Inc.

    Subject of the earnings report, with Q3 GAAP EPS of -$0.03 and revenue of $2.52M (+12% Y/Y).

Related articles

$LCTCMed

Lifeloc Reports Third Quarter 2026 Results

Lifeloc Technologies, Inc (LCTC) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Lifeloc Reports Third Quarter 2026 Results WHEAT RIDGE, Colo., November 16, 2026 -- Lifeloc Technologies, Inc. (OTCID: LCTC), a global leader in the development and manufacturing of breath alcohol and drug testing devices, has announced financial results for the quar

$LCTCMed

Lifeloc Reports Second Quarter 2026 Results

Lifeloc Technologies, Inc (LCTC) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Lifeloc Reports Second Quarter 2026 Results WHEAT RIDGE, Colo., August 13, 2026 -- Lifeloc Technologies, Inc. (OTCID: LCTC), a global leader in the development and manufacturing of breath alcohol and drug testing devices, has announced financial results for the quart

$NVDAHighAI 9/10

What's Going On With Nvidia Stock Wednesday

Nvidia (NVDA) reported quarterly earnings of $2.68 per share on revenue of $115.84 billion, beating estimates. Data center sales reached $107.6 billion. The company raised its revenue forecast for the current quarter and long-term growth outlook, but expects no revenue from China. Nvidia also expanded its stock buyback program.

$DISMedAI 8/10

Disney’s Experiences Segment Hit Record Quarterly Revenue of $10.1 Billion as Cruise Days Surged. Can the Momentum Last?

Disney (DIS) reported Q4 2026 revenue of $25.95B, up 16% YoY, with its Experiences segment hitting a record $10.1B. All units grew, with Experiences leading in operating income at $2.25B. Adjusted net income rose 56% to $3.35B, beating estimates. The company plans to invest $60B in Experiences over a decade, focusing on parks and cruises.

$GLADMed

Gladstone Capital (GLAD) Q4 2026 Earnings Call Transcript

Gladstone Capital (GLAD) reported Q4 2026 earnings with net interest margin at 8.2%. Fee income was below average, but incentive fee credit covered 100% of regular distributions. Net asset value declined to $20.77 per share due to unrealized depreciation and a supplemental distribution. Total investment income rose 11.7% for the year, covering distributions at 104.5%. The company discussed its investment strategy and credit management, highlighting its focus on the lower middle market.